Go Fujimoto

582 total citations
17 papers, 457 citations indexed

About

Go Fujimoto is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Go Fujimoto has authored 17 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in Go Fujimoto's work include Microscopic Colitis (3 papers), Hepatitis C virus research (3 papers) and Antifungal resistance and susceptibility (2 papers). Go Fujimoto is often cited by papers focused on Microscopic Colitis (3 papers), Hepatitis C virus research (3 papers) and Antifungal resistance and susceptibility (2 papers). Go Fujimoto collaborates with scholars based in Japan and United States. Go Fujimoto's co-authors include Asako Sato, Hideyo Suzuki, Kenji Nonaka, Michael J. Davies, Naoki Kato, Peter P. Stein, Tuli Ahmed, Kotoba Okuyama, Yukio Hirayama and Takashi Omori and has published in prestigious journals such as Gastroenterology, Osteoporosis International and Journal of Gastroenterology and Hepatology.

In The Last Decade

Go Fujimoto

17 papers receiving 440 citations

Peers

Go Fujimoto
Satoshi Takasaki Japan
Emily Corbould United Kingdom
R de Marco Italy
Jung‐Hyun Lee South Korea
Konstantinos Leivaditis Greece
Jacqueline Porcel United States
Xia Xu China
Ching‐Chih Hu Taiwan
Maryl Kreider United States
Mehdi Nikkhah Iran
Satoshi Takasaki Japan
Go Fujimoto
Citations per year, relative to Go Fujimoto Go Fujimoto (= 1×) peers Satoshi Takasaki

Countries citing papers authored by Go Fujimoto

Since Specialization
Citations

This map shows the geographic impact of Go Fujimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Go Fujimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Go Fujimoto more than expected).

Fields of papers citing papers by Go Fujimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Go Fujimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Go Fujimoto. The network helps show where Go Fujimoto may publish in the future.

Co-authorship network of co-authors of Go Fujimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Go Fujimoto. A scholar is included among the top collaborators of Go Fujimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Go Fujimoto. Go Fujimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nakase, Hiroshi, Toshimitsu Fujii, Yasuo Suzuki, et al.. (2024). Su1795 OZANIMOD AS INDUCTION AND MAINTENANCE THERAPY FOR ULCERATIVE COLITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN JAPAN (J-TRUE NORTH). Gastroenterology. 166(5). S–817. 1 indexed citations
2.
3.
Yoshida, Tsutomu, Go Ogura, Mikiko Tanabe, et al.. (2022). Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan. Cancer Biology & Therapy. 23(1). 191–200. 22 indexed citations
4.
Fujimoto, Go, et al.. (2021). Healthcare resource utilization and economic burden of antifungal management in patients with hematologic malignancy in Japan: a retrospective database study. Current Medical Research and Opinion. 37(7). 1121–1134. 1 indexed citations
5.
Fujimoto, Go, et al.. (2020). The disease burden of mucormycosis in Japan: results from a systematic literature review and retrospective database study. Current Medical Research and Opinion. 37(2). 253–260. 8 indexed citations
6.
Fujimoto, Go, et al.. (2019). The clinical and economic burden of cytomegalovirus management post allogeneic hematopoietic stem cell transplantation in Japan – a retrospective database study. Current Medical Research and Opinion. 35(12). 2089–2096. 8 indexed citations
7.
8.
Arakawa, Soichi, Kazuya Kawahara, Motoshi Kawahara, et al.. (2018). The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection. Journal of Infection and Chemotherapy. 25(2). 104–110. 21 indexed citations
9.
Mikamo, Hiroshige, Kazuteru Monden, Tetsuya Horiuchi, et al.. (2018). The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections. Journal of Infection and Chemotherapy. 25(2). 111–116. 19 indexed citations
10.
Ruzicka, Daniel J., et al.. (2018). Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016. BMC Infectious Diseases. 18(1). 237–237. 15 indexed citations
11.
Mikamo, Hiroshige, et al.. (2017). The effect of bezlotoxumab for prevention of recurrent Clostridium difficile infection (CDI) in Japanese patients. Journal of Infection and Chemotherapy. 24(2). 123–129. 17 indexed citations
12.
Kumada, Hiromitsu, Yoshiyuki Suzuki, Yoshiyasu Karino, et al.. (2016). The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study. Journal of Gastroenterology. 52(4). 520–533. 51 indexed citations
13.
Kumada, Hiromitsu, Satoshi Mochida, Fumitaka Suzuki, et al.. (2016). Vaniprevir plus peginterferon alfa‐2b and ribavirin in treatment‐experienced Japanese patients with hepatitis C virus genotype 1 (GT1b) infection: Phase 3 studies. Journal of Gastroenterology and Hepatology. 31(10). 1674–1683. 2 indexed citations
14.
Rakugi, Hiromi, Takuya Tsuchihashi, Kazuyuki Shimada, et al.. (2014). Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials. Hypertension Research. 37(12). 1042–1049. 1 indexed citations
15.
Nakamura, Toshitaka, Masataka Shiraki, Masao Fukunaga, et al.. (2013). Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis—a double-blind, randomized, dose-finding study. Osteoporosis International. 25(1). 367–376. 33 indexed citations
16.
Nonaka, Kenji, Asako Sato, Kotoba Okuyama, et al.. (2008). Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes. Diabetes Research and Clinical Practice. 79(2). 291–298. 178 indexed citations
17.
Omori, Takashi, Go Fujimoto, Isao Yoshimura, Hiroshi Nitta, & Masaji Ono. (2003). Effects of Particulate Matter on Daily Mortality in 13 Japanese Cities. Journal of Epidemiology. 13(6). 314–322. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoshi Takasaki Breakdown of academic impact, for papers by Emily Corbould Breakdown of academic impact, for papers by R de Marco Breakdown of academic impact, for papers by Jung‐Hyun Lee Breakdown of academic impact, for papers by Konstantinos Leivaditis Breakdown of academic impact, for papers by Jacqueline Porcel Breakdown of academic impact, for papers by Xia Xu Breakdown of academic impact, for papers by Ching‐Chih Hu Breakdown of academic impact, for papers by Maryl Kreider Breakdown of academic impact, for papers by Mehdi Nikkhah
Rankless by CCL
2026